Abstract:Aims/hypothesis: Diabetic ketoacidosis (DKA) is often caused by concomitant systemic inflammation and lack of insulin. Here we used an experimental human model to test whether and how metabolic responses to insulin are impaired in the early phases of DKA with a specific focus on skeletal muscle metabolism. Methods: Nine individuals with type 1 diabetes from a previously published cohort were investigated twice at Aarhus University Hospital using a 120 min infusion of insulin (3.0/1.5 mU kg-1 min-1) after an overnight fast under: (1) euglycaemic conditions (CTR) or (2) hyperglycaemic ketotic conditions (KET) induced by an i.v. bolus of lipopolysaccharide and 85% reduction in insulin dosage. The primary outcome was insulin resistance in skeletal muscle. Participants were randomly assigned to one of the two arms at the time of screening using www.randomizer.org . The study was not blinded. Results: All nine volunteers completed the 2 days and are included in the analysis. Circulating concentrations of glucose and 3-hydroxybutyrate increased during KET (mean ± SEM 17.7 ± 0.6 mmol/l and 1.6 ± 0.2 mmol/l, respectively), then decreased after insulin treatment (6.6 ± 0.7 mmol/l and 0.1 ± 0.07 mmol/l, respectively). Prior to insulin infusion (KET vs CTR) isotopically determined endogenous glucose production rates were 17 ± 1.7 μmol kg-1 min-1 vs 8 ± 1.3 μmol kg-1 min-1 (p = 0.003), whole body phenylalanine fluxes were 2.9 ± 0.5 μmol kg-1 min-1 vs 3.1 ± 0.4 μmol kg-1 min-1 (p = 0.77) and urea excretion rates were 16.9 ± 2.4 g/day vs 7.3 ± 1.7 g/day (p = 0.01). Insulin failed to stimulate forearm glucose uptake and glucose oxidation in KET compared with CTR (p < 0.05). Glycogen synthase phosphorylation was impaired in skeletal muscle. Conclusions/interpretation: In KET, hyperglycaemia is primarily driven by increased endogenous glucose production. Insulin stimulation during early phases of DKA is associated with reduced glucose disposal in skeletal muscle, impaired glycogen synthase function and lower glucose oxidation. This underscores the presence of muscle insulin resistance in the pathogenesis of DKA. Trial registration www.clinicaltrials.gov (ID number: NCT02157155). Funding This work was funded by the Danish Council for Strategic Research (grant no. 0603-00479B).

Half-life and hypoglycemic effect of intravenous insulin in patients with diabetic ketoacidosis.

The Effect of Glucose and Insulin Infusion on the Fall of Ketone Bodies During Treatment of Diabetic Ketoacidosis

Basal insulin for the management of diabetic ketoacidosis

Changes of blood electrolytes and lipids in type 1 diabetes mellitus children with ketoacidosis (DKA)

Effect of Continuous Subcutaneous Injection of Insulin Analogues in Pregnant Women with Diabetes Mellitus Complicated with Ketoacidosis

Time to Moderate and Severe Hyperglycemia and Ketonemia Following an Insulin Pump Occlusion

Comment on "memory effects in an interacting magnetic nanoparticle system".

Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes

Evaluation of Insulin Dosing Strategies for Hyperkalemia Management at an Academic Medical Center

Pilot Study on the Impact of Early Subcutaneous Basal Insulin Administration in Diabetic Ketoacidosis

Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function

Effects of Acute Insulin Deficiency on Glucose and Ketone Body Turnover in Man: Evidence for the Primacy of Overproduction of Glucose and Ketone Bodies in the Genesis of Diabetic Ketoacidosis

Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?

[Mechanism of action of combined administration of glibenclamide and insulin in type II diabetics with secondary failure of oral treatment]

Dose-response characteristics for effects of insulin on production and utilization of glucose in man

Effect of treating hyperglycemia of type 2 diabetes with continuous subcutaneous insulin infusion

A Randomized Trial of Insulin Glargine Plus Oral Hypoglycemic Agents Versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.

Early Versus Late Administration of Long-Acting Insulin in Adult Diabetic Ketoacidosis

Erythroplasia vs. leukoplasia in the diagnosis of early asymptomatic oral squamous carcinoma.

Current hyperkalemia interventions co-administered with a dextrose 10% solution significantly lower hypoglycemic rates (CHICA-D10)

Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia